SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : biotech fireworks

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nigel bates who wrote (2454)4/3/2006 9:13:56 AM
From: Jibacoa  Read Replies (1) of 7424
 
Besides the news of the deal with GSK on in RNAi-Based Therapeutics for Respiratory Disease
Monday April 3, 7:32 am ET

It is also having the benefit of a patent approval:

Sirna Therapeutics Granted First Broad siRNA Patent for a Gene Target in the United States
Monday April 3, 7:38 am ET

Patent Covers Any Chemically Modified siRNA Sequence Used Against the Targeted Gene and Sets Precedent for Sirna Therapeutics' Substantial Target Patent Portfolio in the U.S.

biz.yahoo.com

It is up more than 16% in pre-market.

Bernard
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext